Dengue and COVID-19 Co-Circulation in the Peruvian Amazon: A Population-Based Study
- PMID: 37094790
- PMCID: PMC10540116
- DOI: 10.4269/ajtmh.22-0539
Dengue and COVID-19 Co-Circulation in the Peruvian Amazon: A Population-Based Study
Abstract
The COVID-19 pandemic affected the main Amazon cities dramatically, with Iquitos City reporting the highest seroprevalence of anti-SARS-CoV-2 antibodies during the first COVID-19 wave worldwide. This phenomenon raised many questions about the possibility of a co-circulation of dengue and COVID-19 and its consequences. We carried out a population-based cohort study in Iquitos, Peru. We obtained a venous blood sample from a subset of 326 adults from the Iquitos COVID-19 cohort (August 13-18, 2020) to estimate the seroprevalence of anti-dengue virus (DENV) and anti-SARS-CoV-2 antibodies. We tested each serum sample for anti-DENV IgG (serotypes 1, 2, 3, and 4) and SARS-CoV-2 antibodies anti-spike IgG and IgM by ELISA. We estimated an anti-SARS-CoV-2 seroprevalence of 78.0% (95% CI, 73.0-82.0) and an anti-DENV seroprevalence of 88.0% (95% CI, 84.0-91.6), signifying a high seroprevalence of both diseases during the first wave of COVID-19 transmission in the city. The San Juan District had a lower anti-DENV antibody seroprevalence than the Belen District (prevalence ratio, 0.90; 95% CI, 0.82-0.98). However, we did not observe these differences in anti-SARS-CoV-2 antibody seroprevalence. Iquitos City presented one of the highest seroprevalence rates of anti-DENV and anti-SARS-CoV-2 antibodies worldwide, but with no correlation between their antibody levels.
Figures



Similar articles
-
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.Lancet Glob Health. 2021 Jul;9(7):e925-e931. doi: 10.1016/S2214-109X(21)00173-X. Epub 2021 May 19. Lancet Glob Health. 2021. PMID: 34022148 Free PMC article.
-
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.Lancet Infect Dis. 2021 Apr;21(4):473-481. doi: 10.1016/S1473-3099(20)30858-6. Epub 2020 Dec 15. Lancet Infect Dis. 2021. PMID: 33338441 Free PMC article.
-
High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.mSphere. 2021 Dec 22;6(6):e0068521. doi: 10.1128/mSphere.00685-21. Epub 2021 Nov 24. mSphere. 2021. PMID: 34817236 Free PMC article.
-
Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Jun 14;19(12):7257. doi: 10.3390/ijerph19127257. Int J Environ Res Public Health. 2022. PMID: 35742506 Free PMC article.
-
Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.Cancer Treat Rev. 2020 Nov;90:102102. doi: 10.1016/j.ctrv.2020.102102. Epub 2020 Sep 1. Cancer Treat Rev. 2020. PMID: 32947121 Free PMC article. Review.
Cited by
-
Clinical Epidemiology of Dengue and COVID-19 Co-infection Among the Residents in Dhaka, Bangladesh, 2021-2023: A Cross-sectional Study.Open Forum Infect Dis. 2025 Jan 25;12(2):ofaf039. doi: 10.1093/ofid/ofaf039. eCollection 2025 Feb. Open Forum Infect Dis. 2025. PMID: 39981071 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous